Too Old to Operate3d
Biologics as a Treatment for Refractory Urticarial Vasculitis
The following is a summary of “Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study,” ...
Hosted on MSN14d
Ukrainian troops withdraw from, launch attack on Chasiv Yar refractory plant
Ukrainian forces launched an aerial attack against a Russian-occupied refractory plant in the embattled city of Chasiv Yar, ...
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma ...
The New England Journal of Medicine24d
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
A total of 87 patients (93%) had disease that was refractory to their last line of therapy, and 81 (86%) had disease that was triple-class refractory. A total of 34 patients (36%) had ...
Pharmabiz2d
March Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma
Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...
Too Old to Operate4d
Surgical Margins and Tumor Location Predict Outcomes in TIO
The following is a summary of “Prognostic factors for refractory outcome in localizing TIO: experience in a tertiary center,” ...
Business Wire4d
Balmoral Consummates the Sale of Resco to RHI Magnesita
RHI Magnesita, the leading global supplier of high-grade refractory products, systems and solutions, is pleased to announce the completion of the acqu ...
Targeted Oncology6d
Novel CAR T-Cell Therapy GCC19CART Active in Refractory mCRC
Preliminary findings from the phase 1 trial showed that GCC19CART, a novel CAR T-cell therapy, demonstrated clinical ...